RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Apr. 4, 2018-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, will showcase the Senhance™ Surgical System at the 16th World Congress of Endoscopic Surgery which is part of the 2018 Annual Meeting of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). The meeting will be held April 11-14, 2018 in Seattle, Washington. Attendance at SAGES is expected to include over 2,500 general, colon & rectal, endoscopic, pediatric, bariatric, and military surgeons as well as allied health professionals from across the United States and around the globe.

The Senhance System will be featured in subooth #131 in the exhibition hall and will be available for demonstrations.

About TransEnterix

TransEnterix is a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options in today's value-based healthcare environment. The Company is focused on the commercialization of the Senhance™ Surgical System, which digitizes laparoscopic minimally invasive surgery. The system allows for robotic precision, haptic feedback, surgeon camera control via eye sensing and improved ergonomics while offering responsible economics. The Senhance Surgical System is available for sale in the US, the EU and select other countries. For more information, visit www.transenterix.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180404006311/en/

Source: TransEnterix, Inc.

For TransEnterix, Inc.
Investor Contact:
Mark Klausner, +1-443-213-0501
invest@transenterix.com
or
Media Contact:
Joanna Rice, +1-951-751-1858
joanna@greymattermarketing.com